✦ LIBER ✦

Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors

✍ Scribed by Yoshihiro Tadori; Robert A. Forbes; Robert D. McQuade; Tetsuro Kikuchi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.d.002 Characterization of aripiprazo

✍ Y. Tadori; A. Forbes; R. McQuade; T. Kikuchi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

The dopamine D3 receptor partial agonist

✍ Karsten Wicke; Javier Garcia-Ladona 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Evidence for antagonist activity of the

✍ Martyn D Wood; Izzy Boyfield; David J Nash; Frances R Jewitt; Kim Y Avenell; Gra 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB

P.3.d.001 In-vitro pharmacology of aripi

✍ Y. Tadori; A. Forbes; R. McQuade; T. Kikuchi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Aripiprazole and its human metabolite ar

✍ Martyn D. Wood; Claire Scott; Kirsten Clarke; Julie Westaway; Ceri H. Davies; Ch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 323 KB

P.3.d.001 Aripiprazole's receptor-reserv

✍ Y. Tadori; H. Kitagawa; A. Forbes; R. McQuade; A. Stark; T. Kikuchi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB